Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesalazine Granules Maintenance in UC
NCT00746447Phase 3Completed
- Sponsor
- Dr. Falk Pharma GmbH
- Start
- May 2005
- Primary completion
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Salcrozine in ulcerative colitis (UC), sponsored by Dr. Falk Pharma GmbH. Started May 2005; status: completed.
02
Drugs
Salcrozine
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT00746447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00746447.